How a major OTC Pharma Company can Increase Revenue by $7.16 Million, 8%-11% Growth
.jpg)
Industry
A global OTC medicine brand
Challenge
The OTC medicine brand needed to pinpoint optimal price points for different pack sizes to maximize revenue without sacrificing volume. They also wanted to uncover price cliffs, gauge elasticity, and benchmark against competitors.
Result
PriceBeam’s analysis revealed a $7.16M revenue uplift opportunity and 8–11% growth across tested SKUs. Smaller packs could sustain double-digit price increases before volume loss, while larger formats faced clear price caps.
$7.16M
REVENUE UPLIFT OPPORTUNITY8–11%
POTENTIAL REVENUE INCREASE
42%
BRAND PREFENCE AMONG RESPONDENTS
.jpg?width=500&height=419&name=A%20global%20OTC%20medicine%20brand%20(1).jpg)
About the Brand
A global consumer healthcare leader with a strong OTC medicine portfolio, widely trusted for quality, efficacy, and consumer loyalty. Their products are used in markets worldwide for everyday self-care needs.
The Impact
Using PriceBeam’s Revenue Growth Management Study, which combined WtP and value driver analysis, the brand gained a clear roadmap for pricing. The study uncovered $7.16M in revenue potential and 8–11% growth, achievable by adjusting pack prices without added costs or risking consumer loyalty.
“The study showed us exactly where our prices could move without losing customers. We now have a clear map of optimal price points for each format, helping us balance revenue growth with brand strength. The insights were precise, actionable, and easy to implement.”
We have worked with leading brands in the pharmaceutical and OTC sector.
Speak with our team, let's discuss your revenue challenges and find the right solution for your brand.

Customer Case Study:
How a consumer brand increased revenue by 25% with PriceBeam's Willingness-to-Pay study.